| ID | Sequence | Length | GC content |
|---|---|---|---|
| lnc-SNRPN-1:10 | CGUUUGUUUCCUUCAUGUAGAUUGCUGUGUGUGUCUUUUUCUUCAUAAU… | 320 nt | 0.3781 |
| lnc-SNRPN-1:11 | CGUUUGUUUCCUUCAUGUAGAUUGCUGUGUGUGUCUUUUUCUUCAUAAU… | 13183 nt | 0.3440 |
| lnc-SNRPN-1:12 | UUUCCUUCAUGUAGAUUGCUGUGUGUGUCUUUUUCUUCAUAAUUCCCCU… | 3373 nt | 0.3575 |
| lnc-SNRPN-1:13 | CUUCAUGUAGAUUGCUGUGUGUGUCUUUUUCUUCAUAAUUCCCCUUAAU… | 310 nt | 0.3774 |
| lnc-SNRPN-1:14 | GAUACUUCACAGAUGACUUAAAAUAAAUCCCCUGAAAAUAAGAAUCUCU… | 2697 nt | 0.3393 |
| lnc-SNRPN-1:15 | CAAUUCUGUAUUCACUUUUUGAGUGCAUAAGGGUAAUAGAAAAUGACAU… | 268 nt | 0.2649 |
| lnc-SNRPN-1:16 | CCUGGAUAGAGCUGGAGACCAUUUAACUGCUGUAUGAAUAAUAGAUAAG… | 567 nt | 0.3880 |
No relevant information is available at the moment.
A study in human and mouse models demonstrated that the lncRNA PWAR5 is downregulated in liver tissue and its expression is associated with poor prognostic outcomes specifically in HCV-related hepatocellular carcinoma [Machida DOI:10.1016/J.Cbi.2020.109055].